Risk Factors for Discontinuation of S-1 Adjuvant Chemotherapy for Gastric Cancer

Purpose: The aim of this study was to clarify the risk factors for discontinuing tegafur/gimeracil/oteracil potassium (S-1) adjuvant chemotherapy following gastrectomy in patients with gastric cancer. Methods: We retrospectively investigated patients with curatively-resected gastric cancer who recei...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawazoe, Hitoshi, Shimasaki, Maya, Ueno, Masaki, Sumikawa, Satomi, Takatori, Shingo, Namba, Hiroyuki, Yoshida, Motohira, Sato, Koichi, Kojima, Yoh, Watanabe, Yuji, Moriguchi, Toshihide, Tanaka, Akihiro, Araki, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392055/
https://www.ncbi.nlm.nih.gov/pubmed/25874010
http://dx.doi.org/10.7150/jca.11189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4392055/
https://www.ncbi.nlm.nih.gov/pubmed/25874010
http://dx.doi.org/10.7150/jca.11189

Ejemplares similares